Literature DB >> 21245973

7 Procoagulators.

.   

Abstract

Year:  2009        PMID： 21245973      PMCID： PMC2997297     

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  86 in total

1.  Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary.

Authors:  P Hellstern; W M Halbmayer; M Köhler; R Seitz; G Müller-Berghaus
Journal:  Thromb Res       Date:  1999-08-15       Impact factor: 3.944

Review 2.  Coagulation factor deficiencies and pregnancy loss.

Authors:  Aida Inbal; Laszlo Muszbek
Journal:  Semin Thromb Hemost       Date:  2003-04       Impact factor: 4.180

3.  Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders.

Authors: 
Journal:  Haemophilia       Date:  2003-01       Impact factor: 4.287

Review 4.  [Perioperative coagulation disorders].

Authors:  R U Scherer; R M Giebler
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2004-07       Impact factor: 0.698

Review 5.  [Liver cirrhosis and coagulopathy].

Authors:  I Scharrer
Journal:  Hamostaseologie       Date:  2005-05       Impact factor: 1.778

6.  Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.

Authors:  Kathryn A O'Connell; Jennifer J Wood; Robert P Wise; Jay N Lozier; M Miles Braun
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

7.  Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates.

Authors:  M Köhler; P Hellstern; E Lechler; P Uberfuhr; G Müller-Berghaus
Journal:  Thromb Haemost       Date:  1998-09       Impact factor: 5.249

8.  Comparative in vitro investigation of prothrombin complex concentrates.

Authors:  J Römisch; K Bonik; H G Müller
Journal:  Semin Thromb Hemost       Date:  1998       Impact factor: 4.180

9.  Pharmacokinetic properties of a pasteurised fibrinogen concentrate.

Authors:  Wolfhart Kreuz; Esther Meili; Kristiina Peter-Salonen; Alena Dobrkovská; Jan Devay; Sabine Haertel; Udo Krzensk; Rudolf Egbring
Journal:  Transfus Apher Sci       Date:  2005-06       Impact factor: 1.764

Review 10.  The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review.

Authors:  M Franchini; D Veneri; G Lippi
Journal:  Bone Marrow Transplant       Date:  2007-04-09       Impact factor: 5.483
View more
  3 in total

Review 1.  Fibrinogen replacement therapy: a critical review of the literature.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2011-11-15       Impact factor: 3.443

2.  Coagulopathy in a subtype of choledochal cyst and management strategy.

Authors:  Mei Diao; Long Li; Wei Cheng
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

3.  Massive Bleeding and Massive Transfusion.

Authors:  Andreas Meißner; Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2012-03-12       Impact factor: 3.747
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.